From Surf Wiki (app.surf) — the open knowledge base
Co-danthrusate
Pharmaceutical combination
Pharmaceutical combination
| Drugs.com =
Co-danthrusate is a combination of dantron and docusate. Dantron is a mild peristaltic stimulant which acts on the lower bowel to encourage normal bowel movement without causing irritation. It belongs to the group of medicines under the term stimulant laxative. It stimulates the nerves in the stomach wall, which causes the stomach muscles to contract. This medicine is used for analgesic-induced constipation. It takes six to twelve hours to work. This can cause discoloration of urine and bowel and liver tumors.
Co-danthramer is dantron plus poloxamer. It is (in the U.K.) only to be prescribed to terminally ill patients because of its carcinogenicity in rats. It is often prescribed to people taking long term opioid, because it relaxes the effect of opioid induced constipation. It will not alleviate the symptoms of opioid induced delayed gastric emptying and abdominal cramps.
References
References
- "Constipation in Adults information. Causes and Treatment".
- (20 August 2007). "Co-danthrusate".
- "co-danthrusate suspension".
- (April 2010). "Constipation in people prescribed opioids". BMJ Clinical Evidence.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Co-danthrusate — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report